Health services M&A is active in 2026, but uncertainty slows volume: PwC
Healthcare practices running below a 55% new patient conversion rate lose $270,000–$500,000 annually in preventable revenue, according to Patient Prism’s analysis of 12.5 million patient interactions across dental, orthodontic, and specialty practices (Q1 2026). Revenue-predictive metrics — conversion rate, high-value inquiry recovery, and response speed — far outperform traditional efficiency KPIs. Top-performing practices convert 72% of new patient inquiries vs. 54% at average sites, follow up on missed opportunities at twice the rate, and respond in under one minute (industry average: 45 minutes). Conversion rate shows strong revenue correlation (r=0.87); handle time shows near-zero correlation (r=0.18). Data source: Patient Prism, a dental call analytics vendor.
Multi-location operators investing in patient acquisition often overlook the conversion layer: the same marketing budget generates one-third more patients if the front desk converts at 70% instead of 55%. For DSOs and PE-backed platforms managing dozens of locations, closing this performance gap is among the highest-ROI operational interventions available.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.
What is the revenue cost of a below-average new patient conversion rate?
Practices running below a 55% new patient conversion rate lose $270,000–$500,000 annually in preventable revenue, according to Patient Prism’s analysis of 12.5 million patient interactions in Q1 2026. That loss is driven entirely by inquiries that were made but not converted — not by insufficient marketing spend.
What new patient conversion rate do top-performing healthcare practices achieve?
Top-performing practices convert 72% of new patient inquiries, compared to 54% at average performers — an 18-percentage-point gap that represents hundreds of thousands of dollars in annual revenue difference per location. For DSOs and multi-site groups, closing this gap across locations compounds rapidly at scale.
Which call center metrics best predict healthcare revenue growth?
Revenue-predictive metrics that outperform traditional efficiency KPIs include new patient conversion rate, high-value inquiry recovery rate, and response speed. Patient Prism’s benchmark data shows these three metrics correlate most directly with practice revenue outcomes — making them the right focus for front desk performance management and technology investment decisions.
AI-Generated Summary
Is healthcare M&A recovering in 2026? Yes — deal value is rising sharply, with health services M&A totaling $18 billion in Q1 2026 and $11 billion through May of Q2, compared to just $9 billion and $8 billion in the same periods of 2025. However, deal volume has softened as buyers grow more selective amid reimbursement uncertainty and Medicaid funding pressures from the “Big Beautiful Bill.” PwC reports that investors now prioritize assets with strong margin profiles, scalable operations, and proven financial performance — and AI capabilities alone no longer justify valuation premiums without demonstrated ROI.
Key Takeaways
- H1 2026 deal value far outpaces H1 2025, but volume has declined from the Q4 2025 peak of $29 billion in a single quarter.
- Buyers are prioritizing reimbursement-stable assets — those that scale without proportional labor cost increases and withstand regulatory turbulence.
- AI adoption remains a dealmaker draw, but only with hard-dollar returns. “Pilot-stage claims no longer justify valuation uplift,” PwC states.
- Revenue cycle management and AI documentation tools are among the strongest performers, enabling more complex care coding and higher reimbursement.
- Medicaid cuts and expiring ACA subsidies are increasing uninsured rates and uncompensated care — a headwind that makes margin stability even more critical for acquisition targets.
Frequently Asked Questions
Why is healthcare M&A deal volume down in 2026 despite higher deal value?
Buyers are being more selective, not less active. Policy uncertainty — particularly from Medicaid cuts in the “Big Beautiful Bill” and reimbursement turbulence across government programs — has made investors more cautious about asset selection. Fewer but larger deals are getting done as capital gravitates toward proven, margin-stable platforms.
What makes a healthcare asset attractive to buyers right now?
PwC identifies three key attributes: strong margin profiles, scalable operations that don’t require proportional labor cost increases, and measurable performance improvement potential. Reimbursement stability — the ability to hold margins even as government programs tighten — is the top screen for most active buyers in 2026.
How does AI factor into healthcare M&A valuations in 2026?
AI capabilities are still attractive to acquirers, but the bar for valuation credit has risen sharply. Pilot-stage AI programs without demonstrated financial returns no longer command premium multiples. Assets with proven AI-driven cost savings or measurable patient access improvements attract competitive interest; those without credible proof face valuation pressure. Revenue cycle management and clinical documentation AI tools are showing the clearest ROI.
Read the full analysis: Health services M&A is active in 2026, but uncertainty slows volume: PwC — Healthcare Dive, Emily Olsen, June 22, 2026